Sumiyo
Sumiyo Kato, Chiyoda-Ku JP
Patent application number | Description | Published |
---|---|---|
20100199928 | WOUND-PROTECTION WEAR FOR ANIMAL - A full body suit type wound-protection wear comprising a stretchable cloth in which at least one elongation percentage in a warp direction and a weft direction is 40% or more and at least one elastic recovery percentage of elongation in warp direction and a weft direction is 80% or more is wore on an animal, and then partially cut off if needed. The wound-protection wear for an animal thus obtained is easy to put on and take off, has appropriate tightness (giving no pain to an animal), and enables wound protection while covering various affected parts on the body of an animal. As a result, a veterinarian and an owner can effectively treat the animal. | 08-12-2010 |
Sumiyo Morita, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20090197317 | TSG-Like Gene - A gene encoding a novel protein that is homologous to | 08-06-2009 |
Sumiyo Nishi, Ibaraki-Shi JP
Patent application number | Description | Published |
---|---|---|
20100048628 | METHOD FOR SUPPRESSING DISCOLORATION OVER TIME OF ADHESIVE PREPARATION CONTAINING DONEPEZIL - [Object] Discoloration, over time, of a donepezil-containing adhesive preparation is suppressed. | 02-25-2010 |
20100062045 | METHOD FOR SUPPRESSING COLORING OF ADHESIVE PREPARTION CONTAINING DONEPEZIL AND METHOD FOR REDUCING AMOUNTS OF DONEPEZIL-RELATED SUBSTANCES FORMED - [Object] By suppressing coloring of an adhesive preparation containing donepezil, a naturally colored appearance is realized. | 03-11-2010 |
Sumiyo Shiosaka, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20100222114 | PORTABLE INFORMATION TERMINAL EQUIPMENT - Portable information terminal equipment having a function to perform the informing process at the time of reception in cooperation with a connecting section driving mechanism as well as a function to enable the open/close movement of the upper and lower units through one-touch operation making use of the connecting section driving mechanism. Depending on informing modes, a motor drive circuit drives a motor under the control of a controller on receipt of a call or a message to apply a driving force to the open/close mechanism of a hinge unit. Thereby, the portable information terminal equipment is folded/unfolded, that is, the posture of the portable information terminal equipment is changed, and a user is informed of the receipt of the call or the message. Besides, the portable information terminal equipment performs conventional informing processes, such as ringing, light emitting, message or image display and the like, in combination with the open/close or rotative operation. | 09-02-2010 |
20120028689 | PORTABLE INFORMATION TERMINAL EQUIPMENT - Portable information terminal equipment having a function to perform the informing process at the time of reception in cooperation with a connecting section driving mechanism as well as a function to enable the open/close movement of the upper and lower units through one-touch operation making use of the connecting section driving mechanism. Depending on informing modes, a motor drive circuit drives a motor under the control of a controller on receipt of a call or a message to apply a driving force to the open/close mechanism of a hinge unit. Thereby, the portable information terminal equipment is folded/unfolded, that is, the posture of the portable information terminal equipment is changed, and a user is informed of the receipt of the call or the message. | 02-02-2012 |
Sumiyo Watanabe, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20150080454 | UNIT STRUCTURE-TYPE PHARMACEUTICAL COMPOSITION FOR NUCLEIC ACID DELIVERY - A unit structure-type pharmaceutical composition includes at least one nucleic acid, such as siRNA, electrostatically bound to at least one block copolymer having a cationic polyamino acid segment and a hydrophilic polymer chain segment. The negative charge(s) of the nucleic acid are counterbalanced, at least substantially, by the positive charge(s) of the cationic polyamino acid segment such that the pharmaceutical composition is electrically neutral or nearly electrically neutral. Further, the nucleic acid is covered with the hydrophilic polymer chain segment(s). The at least one block copolymer thereby improves the blood retention capability of the nucleic acid(s). | 03-19-2015 |